In the United States, prescription rates for LAIs have been estimated at only 8% of schizophrenia patients receiving treatment (estimated from the IMS Multinational Integrated Data Analysis System databse,Q 3 2011-Q2 2012 [Ray Lansigan, personal communication, February 13,2013]).